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SUMMARY 
The ATP content and intracellular pH (pHJ3 of isolated rat 
liver before, during, and after cold preservation in either UW-
lactobionate (UW, n=10) or Euro-Collins (EC, n=8) solutions were 
monitored using phosphorus-31 nuclear magnetic resonance (31 P-
NMR) spectroscopy. The 31 P-NMR spectra were obtained on a 4.7-
Tesla system operating at 81 MHz. Fructose metabolism, liver 
enzyme release, 02 consumption, and rat survival after liver 
transplantation were also evaluated. During simple cold storage 
(SCS), the ATP level declined to undetectable levels with both 
preservation solutions while the pHi declined to approximately 7.0. 
In contrast, during continuous hypothermic perfusion (CHP), hepatic 
ATP levels remained measurable during the 24-hour EC preservation 
and actually increased significantly (p>0.01) during UW preservation. 
After reperfusion at 37°C with Krebs-lactate, the SCS livers treated 
with EC differed significantly from the UW livers in terms of their 
ATP and pHi as well as their response to a fructose challenge. In 
contrast, livers undergoing CHP demonstrated similar behaviors 
with both solutions. These results demonstrate an increase in the 
hepatic ATP content during CHP which occurs with UW but is not 
seen with EC. On the other hand, only livers that Vlere simply stored 
with UW achieved significant survival after transplant, while CHP 
livers were affected by vascular damage as demonstrated by fatal 
thrombosis after transplant. These data suggest that ATP content i~K 
not the only determinant of good liver function although a system of 
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hypothermic perfusion might further improve liver preservation 
efficacy should injury to vascular endothelium be avoided . 
. ;;, 
. . 
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INTRODUCTION 
Clinical liver transplantation has changed markedly since the 
introduction of the University of Wisconsin (UW) preservation 
solution (1). With this solution, the cold preservation time for a 
liver has been extended to 24 hours (2-4), considerably longer than 
that which can be achieved with the Euro-Collins (EC) solution (5). 
The impact of this extension in cold preservation time on the 
logistics and costs of liver transplantation has been substantial: 
almost immediately, both a wider procurement and better 
distribution of donor organs became possible. Moreover, fewer donor 
organs are wasted, and the transplant procedure itself has become a 
semi-elective operation rather than an urgent procedure at most 
institutions. Most importantly, graft survival after preservation 
with the UW solution has increased and a reduced frequency of 
primary graft non-function and hepatic artery thrombosis has been 
observed compared to that which had been achievable with the EC 
solution (4, 6-8). 
The precise mechanisms responsible for the improvement in 
transplant success achieved with the UW cold preservation solution 
is not yet clear. In designing the solution, Belzer and associates (9) 
combined the available knowledge relative to Jhe principles of 
anaerobic cold ischemia with known principles of liver metabolism. 
The constituents of the UW solution were chosen in an effort to 
create a solution that would prevent: hypothermic-induced cell, 
swelling, intracellular acidosis, expansion of the interstitial space, 
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injury from oxygen-free radicals, and depletion of the tissue 
adenosine phosphate content (ATP, ADP, etc.) (9, 10). 
Several studies have attempted to relate the hepatic content 
of ATP in a donor liver with the degree of post-operative graft 
function (11-13). Each of these reports has suggested that the 
ability· of the liver to recover from the many insults experienced 
between the donor and recipient operations can be predicted from 
the A TP content of the donor organ at the time of transplant and/or 
the rapidity of its restoration after reperfusion. Hepatic ATP levels 
also· correlate highly with the rate of subsequent bile flow, a 
parameter currently used as an early post-operative sign of good 
graft function (11). 
Phosphorus-31 nuclear magnetic resonance (31 P - N M R) 
spectroscopy allows non-invasive monitoring of tissue phosphorus 
compound levels (ATP, ADP, etc.), of fructose metabolism and of the 
intracellular pH (pHi) both in vivo and .u vivo (14-18). 
The purpose of this study was to evaluate the metabolic 
function, ATP content and pHi of isolated rat liver using two models 
of liver preservation: simple cold storage (SCS) and continuous 
hypothermic perfusion (CHP) with both UW and EC solutions. The 
questions whether the ATP content and the pHi at any time during the 
preservation and recovery period are reliable ;.indices of organ 
viability and whether 31 P-NMR spectroscopy can provide a valuable 
non-invasive tool in assessing the efficacy of preservation have 
been addressed. 
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METHODS 
Study Design 
The present study was designed to allow a baseline evaluation 
by 31 P-NMR spectroscopy of isolated and perfused rat liver followed 
by the sequential events similar to those occurring during organ 
procurement, liver preservation, and transplantation. For this 
reason the following phases were performed: (i) liver isolation; (ii) 
Perfusion with Krebs-lactate (KL) at 37°C and fructose challenge; 
(iii) cooling; (iv) preservation at 6-10 °C (by two methods) with UW 
or EC; (v) reperfusion; and (vi) re-evaluation with perfusion with 
Krebs-lactate (KL) at 37°C and fructose challenge. 
Finally, in separate experiments, rat liver transplantation was 
performed in a representative number of livers after 24 hr of SCS or 
CHP. 
Rat livers were surgically isolated (phase 1, see: Animals and 
Surgical Procedures) and connected to a perfusion apparatus. Each 
liver was perfused with KL at 37°C for 20 min to achieve a stable 
baseline before 31 P-NMR spectra were collected. In separate control 
experiments, a stable base-line for 02 consumption, lactate 
dehydrogenase (LDH) leakage, glucose production, and 31P-NMR 
spectra were obtained within 15-20 min frorn the isolation-
perfusion of the liver. These parameters were stable for more than 
6 hr under normothermic perfusion with KL. No livers were 
discarded in the present data set for technical reasons. 
A fructose load was administered and its metabolism followed 
for an additional 40 min (phase 2, fructose before preservation) 
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after which the temperature was reduced to 6-10°C while 
simoultaneously switching the preservation solution, stopping the 
oxygenation, reducing the flow rate and recycling the perfusate 
(phase 3, cooling). Livers were then randomly assigned to either be 
stored (SCS) or continuously perfused at a low flow (CHP) with 
either UW or EC at 6-10°C (phase 4, preservation). Before closing 
the perfusion cycle, enough perfusate (UW or EC, approximately 100 
ml) was used to flush the liver and the NMR cell, in order to avoid 
significant contamination of the preservation solution with KL. 
After 24 hr of cold preservation, the livers were reperfused at 37°C 
with oxygenated KL (phase 5, reperfusion) and organ function was 
reassessed by examining the response to, a second fructose load 
(phase 6, fructose after preservation). 
Throughout the experimental period, 31 P-NMR spectra were 
collected to monitor the intrahepatic content of phosphate 
metabolites (ATP, PM, Pi, F-1-P) and pHi. Perfusate samples were 
collected periodically to determine oxygen consumption, pH, LDH, and 
glucose content. 
Animals and I Surgical Procedure 
Male Sprague Dawley rats (200-250 g) were used as liver 
donors. They were provided free access to wat~r and food until 
sacrifice under methoxifluorene anesthesia. Three hundred units of 
heparin was administered intravenously via the penile vein to 
prevent vascular thrombosis during the hepatectomy. The abdomen 
was entered through a midline abdominal incision and the infrarenal 
aorta was cannulated with a 20G catheter. The liver was perfused in 
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~ with 20 ml of cold (4°C) Lactated Ringer's solution, after 
incising the inferior vena cava above and below the liver and 
clamping the aorta proximal to the celiac axis. Immediately 
thereafter the liver was cooled in..s.l.t.u..; the portal vein was 
cannulated using a second 20G catheter and the liver was 
continuously perfused with cold Lactated Ringer's via the portal vein 
and the aorta while the liver was being excised. The total ischemic 
time from the point of aortic clamping and flushing of the liver to 
time of initiation of the hepatic perfusion was less than six min in 
all cases. 
Isolated Liver Perfusion 
A wooden platform was constructed using non-mag netic 
holders for the glass condenser, a temperature probe, a glass syringe 
serving as a bubble-trap, a 30-mm diameter NMR sample tube, and 
Tygon tubing and connectors. The perfusion pump, the water bath, 
and the thermostat regulating the perfusate flow and temperature 
were placed in a room adjacent to the magnet. Insulated tubing was 
used to deliver the perfusate to the liver. The isolated rat liver 
with a pre-weighed catheter inserted in the portal vein was weighed 
and transferred to the NMR sample tube pre-filled with cold KL 
solution connected to the perfusion apparatus._. The liver was 
K~ 
perfused within the NMR sample tube which was placed inside the 
horizontal 40-cm diameter bore of the magnet. Three-way 
stopcocks were positioned in the system to allow for sampling of 
the perfusate at the out- and the in-flow sites of the perfused liver 
as well as for switching from one perfusion solution to another. 
_ .. _ ....•.. _--------------------
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Before and after liver preservation, during phases 2 and 6, the 
KL was placed in a water-jacketed 4-liter perfusate reservoir 
connected to a 37°C water bath and pumped through the liver but 
without recycling. The flow rate during this perfusion at 37°C was 
maintained at 3 ml/min/g of liver (wet weight) and a 95%/5% 
02/C02 gas mixture was bubbled continuously into the perfusate 
reservoir at a constant pressure through a filter-stone. A filter 
valve allowed for the release of pressure within the reservoir as the 
gas was bubbled through the perfusate. 
During phase 4 (preservation at 6-10 °C), a 2S0-ml Erlenmeyer 
flask containing the cold preservation solution (UW or EC) was 
maintained inside a cold water bath and connected to the pump using 
a recycling system. The perfusion rate during this phase of the 
study was 0.5 ml/min/g of wet liver weight. No oxygen was bubbled 
into the perfusate solution during this period. When the temperature 
reached 6°C in the NMR sample tube, the perfusate flow was stopped 
for the SCS experiments. 
After 24 hr of preservation (SCS or CHP), the livers were 
reperfused with oxygenated KL at 37°C at a rate of 3 ml/min/g 
(phase 5, reperfusion). After a 30-min wash-out period, a second 
fructose load was delivered (phase 6, fructose after preservation). 
Continuous temperature calibration using a.n on-line thermo-
.. 
couple adjacent to the NMR probe allowed for maintenance of the 
perfusate temperature throughout every phase of the experiment. 
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Organ Viability 
Hepatic viability was assessed continuously by measuring 
oxygen consumption (Radiometer AB2, Copenhagen), calculated from: 
[(p02inflow - p02outflow) - p02blank] multiplied by flow rate; LDH release 
into the perfusate solution, and glucose production. The livers were 
weighed both before and after each experiment. Basal LDH release 
into the perfusate during oxygenation and perfusion ranged between 
20-35 U/L in phases 2, 5 and 6; 02 consumption was 1.95±0.2 
Ilmol/g/min and glucose production was 5±0.15 mg%. The metabolic 
response of the liver to a physiologic fructose challenge was 
assessed before and after preservation by monitoring the appearance 
and disappearance of the fructose-1-phosphate (F-1-P) peak in the 
31 P-NMR spectra and the initial reduction and subsequent recovery 
of hepatic ATP content induced by the fructose load (0.15 mmole/g 
wet liver weight in 150 ml oxygenated Krebs-lactate, as a 5-min 
bolus). 
31 P-NMR Spectral Measurements 
The 31 P-NMR spectra were obtained using a Bruker BIOSPEC II 
4.7-Tesla system equipped with a 40-cm;- horizontal bore 
superconducting solenoid. The signal was acquired by means of a 
3.5-cm solenoid coil placed around the 30-mm diameter NMR tube 
containing the liver and tuned to 81 MHz for 31 P. The 31 P pulse 
width and the interpulse delay were 70 ~sec and 2 sec except during 
the fructose study when the above 31 P parameters were 35 ~sec and 
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0.3 sec, respectively. In the latter acquisitions, partial saturation 
of phosphomonoesters (PM) and inorganic phosphate (Pi) were 
considered. Under similar conditions, as recently reported by 
Del mas-Beauvieux fi.at (19), no significant differences in 
longitudinal relaxation time (T1) and saturation parameters for the 
phosphate metabolites of interest were observed under the various 
experimental phases and temperatures. 
The 31 P-NMR spectra were obtained before, during, and 24 hr 
after low-temperature preservation (SCS or CHP) using either UW or 
EC. During phases 2 and 6 (KL perfusion at 3]oC), 31 P-NMR spectra 
were recorded as 10-min blocks of 300 scans to establish a 
baseline, followed by 4-min blocks of 600 scans during the fructose 
challenge, and finally additional 10-min blocks during the cooling 
period (phase 3) and the reperfusion period (phase 5). During phase 4 
of the continuous hypothermic perfusion (CHP), 30-min blocks of 
900 scans were recorded continuously for 24 hours. Finally, during 
phase 4 of the SCS livers, spectra were acquired until AT? was 
observed in 31 P-NMR spectra. 
A 5-mm spheric bulb containing a 0.15 M solution of 
methylenediphosphonic acid (MDPA) in D20 at pH 9 was pl~ced in the 
center of the NMR sample tube among the liver lobes to serve as a 
31 P chemical shift and signal intensity reference for the 
. -
intracellular pH determination and relative. concentration 
measurements. 
A calibration plot for determining the intracellular pH from 
the 31 P chemical shifts of Pi and F-1-P was developed using liver 
homogenate at 37°C containing 20 mM EDTA. After the addition of 
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10 mM F-1-P and 10 mM per, a titration curve (from pH 4.24 to 9.45) 
was generated. For each pH studied, the solution was positioned in 
the magnet and 10-min acquisitions were accumulated using a 3.5-
cm diameter solenoid coil, 90° pulses, and a 5-sec interpulse delay. 
The 31 P-NMR chemical shifts were referenced to the PCr, taken as 0 
parts per million (ppm). The 31 P signal of MDPA occurs at 20 ppm 
down field from PCr. Titration curves were obtained by plotting the 
31 P chemical shifts of Pi and F-1-P as a function of pH. A least-
square fit was performed to establish the titration parameters for 
each curve. The intracellular pH (pH) was determined using the 
following equations (20): 
for Pi , and 
pHi = pKF.1•P + log (cr F.1. P - 3.68)/(7.48 - cr F. 1oP) 
for F-1-P, where pKp and pK are 6.76 and 6.03, cr and cr are 
i F·1·P Pi F·1·P 
the observed values of the chemical shift in ppm of Pi and F-1-P, 
respectively. The difference between the two determinations, when 
both peaks are present in the 31 P-NMR spectra, is Jess than 0.05 pH 
unit. Calibration curves prepared in KL provided equivalent 
info rmation. 
A similar calibration plot at 10°C was developed in order to, 
measure pH from the 31 P chemical shifts of Pi and PM during liver 
preservation. 
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The levels of phosphate metabolites (ATP, F-1-P, Pi) were 
determined by integrating the area under the curve for the 
appropriate peak in the 31 P-NMR spectra normalized to the MDPA 
area which served as a reference. When sequential changes were 
followed, peaks were normalized to the initial 31 P-NMR spectrum 
obtained after the equilibration period (100%). 
Liver Transplantation 
Rat liver transplantation of organs preserved either by SCS or 
CHP for 24 hr was performed according to the method of Kamada and 
Caine (21). Function of the transplanted liver was assessed for up 
to 3 days or determined by gross appearance of the organ, the portal 
vein, and the bile flow. 
Materials 
Krebs solution (22) with 1 mM L(+)lactic acid (Sigma) 
neutralized with NaOH (to pH 7.4 at 37°C) was used before and after 
cold preservation to perfuse the livers at 37°C. It was bubbled 
continuously with a 95%/5% 02/C02 gas mixture and infused at a 
rate of 3 ml/min/g liver wet weight. The Euro-Collins (23) was 
purchased from Fresenius AG (Germany) and the UW (24) solution 
was a gift from the Dupont. All other chemicals l;lsed were reagent 
grade and were purchased from either Fisher, Sigma, or Abbott. 
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Statistical Analysis 
The statistical analyses were performed using the Student's t 
test for paired or unpaired data. A p<O.05 was considered to be 
significant. All results are expressed as mean values ± SO . 
-;. 
. . 
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RESULTS 
Figure 1 a shows a typical 81-MHz 31 P-NMR spectrum obtained 
for a perfused rat liver under normoxic conditions with Krebs-
lactate (1 mM at 37°e, bubbled with 95% 02/5% e02, pH 7.40, 3 
mllmin/g liver wet weight) after a 20-min equilibration period and 
before cold preservation. The PM peak represents the sum of signals 
obtained from various sugar phosphates, glycolytic intermediates, 
and AMP. The 31 P chemical shift of the Pi peak relative to the 
external standard (MDPA) enabled a determination of the pHi which 
was 7.28 ± 0.05 (n=18) in all rat livers perfused under these 
conditions. This finding agrees well with pHi determined in mouse 
liver with PCr peak as an internal standard (2S). The phosphodiester 
(PD) peak consists of the sum of the signals from glycero-3-
phosphocholine, glycerolphosphoethanol-amine, phosphoenolpyruvate 
and other related compounds. The 'Y-ATP-phosphate and B -AD P-
phosphate signals occur about -2.4 ppm downfield from PCr; the (l-
phosphates of both ATP and ADP occur at -7.5 ppm; and the B-ATP 
signal is a single peak at -16 ppm. 
Following the administration of a fructose challenge (Figure 
1 b), major changes were observed in the 31 P;.NMR spectra. An 
increase in the PM area was seen immedi~tely due to an 
accumulation of F-1-P with an associated reduction in the Pi and 
A TP content of the liver. 
The time course of the phosphate metabolites after fructose" 
loading is shown in Figure 2, where data from 18 different perfused 
rat livers are shown. The F-1-P signal appeared in the first 4-min 
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spectrum, providing a 17 ± 16% increase (p<0.01) in the PM area, and 
reached a maximum in the following 4-min (83 ± 34%, p<0.001). It 
subsequently decreased rapidly as the fructose was metabolized. 
This process was complete within 20 min at which time the PM area 
in the 31 P-NMR spectrum returned to its pre-fructose level (2 ± 90/0, 
n.s.). The intrahepatic ATP level declined to about 50% of its initial 
value 8 min after the fructose challenge (48 ± 11%, p<0.001). It then 
gradually recovered reaching a level about 80% of the pre-fructose 
value at 40 min (22 ± 5%, p<0.001). Two hours after the fructose 
challenge the hepatic ATP level had returned to approximately 90% 
of the initial basal value (results not shown). The intrahepatic Pi 
level decreased after the fructose load (8 min; 28 ± 10%, 
p<0.001), then rebounded to a level greater than the pre-fructose 
value (16 min; 47 ± 18%, p<0.001), and was still elevated at 40 min 
(16 ± 14%, p<0.01). Following the fructose load, the pHi fell from a 
value of 7.28 ± 0.05 to 7.14 ± 0.05 (p<0.001) at 12 min and then 
returned to a value close to the original baseline value at 20 min 
(7.2S ± O.OS, n.s.) as measured by either the Pi or the F-1-P chemical 
shift. 
After an initial 20-min equilibration period and the first 
fructose challenge, during which oxygen consumption and LDH 
release were constant, the perfusion solution was ~hanged to one of 
the cold preservation solutions (UW: n=10, or EC: n=8). The flow rate 
was gradually decreased to 0.5 mllmin/g of wet liver weight. When 
the temperature within the NMR sample tube reached SoC. 
(approximately 30 min after switching), the perfusion was either 
stopped (SCS) or continued (CHP) for an additional 24 hr. During this 
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period (phase 3, "cooling"), 31 P-NMR spectra were obtained 
periodically and demonstrated a decline in intrahepatic ATP to a 
level approximately 30% of the initial value (UW: 35 ± 80/0, n=10; EC: 
25 ± 9%, n=8, n.s.) and the pHi from 7.25 ± 0.05 to 7.20 ± 0.05, with 
no significant difference being evident among the various groups. 
When the livers were simply stored (SCS) for 24 hr, hepatic 
ATP decreased within a few hours to undetectable levels (results 
not shown), confirming the findings of Busza et al. (26). The pHi 
declined also to a value of 6.9 ± 0.1 (n=9, p<0.01). Although the time 
course of intrahepatic ATP decline was slower in the UW stored 
livers (n=5) as compared with those stored in EC (n=4), the 
difference was not statistically significant. 
In Figure 3, sequential 31 P-NMR spectra are shown from livers 
continuously perfused (CHP) with UW solution at low temperature 
for 24 hr. The a-ATP and ~-Aqm peaks (right) have been measured to 
demonstrate the increase in area with time. The results are 
summarized in Figure 4 where the relative intrahepatic ATP 
concentrations are plotted for both the UW and EC experiments. The 
difference in ATP levels achieved with the two solutions was 
significant (UW: 55 ± 6%, n=5; EC: 26 ± 10, n=4, p<0.01) at 24 hr. The 
pHi fell from a value of 7.20 ± 0.05 to a value of 7.10 ± 0.05 (p<0.01) 
for both solutions. .;. 
At reperfusion after 24 hr of SCS, the livers preserved with EC 
demonstrated less recovery of their ATP levels as compared to the 
UW solution (EC: 35 ± 10%, n=4; UW 65 ± 90/0, p<0.01) and a very poor.: 
response to the fructose load (PM area increase at 8 min: EC 51 ± 
200/0, UW 93 ± 28%, p<0.01). The intracellular pH rapidly returned to 
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normal in UW preserved livers (7.30 ± 0.05, n=5), whereas EC livers 
continued to have lower pHi (7.20 ± 0.05, n=4, p<0.05). 
In the CHP experiments, following reperfusion, the hepatic ATP 
recovery averaged about 80% in both groups (UW: 84 ± 10%, n=5; EC: 
79.5 ± 10, n=4, n.s.) (Figure 4), and a similar increase in the PM area 
after the fructose load was observed (at 8 min; UW: 112 ± 42%, EC: 
91 ± 56%, n.s.). The recovery of hepatic ATP 40 min after fructose 
was greater in UW livers as compared to EC (UW: 60 ± 7%, n=5; EC: 44 
± 10, n=4, p<0.05). There was a long lag period between first and 
second fructose challenge (24 hr), ATP, Pi and pHi were constant 
before each fructose challenge. Intracellular· pH returned to normal 
with both solutions (7.30 ± 0.05, n=9). 
The results of the transplant experiments performed using the 
24-hr cold stored and perfused liver are shown in Table 1. Cold 
storage with the UW solution allowed for prolonged function of the 
transplanted liver. After 24 hr of cold perfusion with EC solution, 
the transplanted livers all ceased to function within 15 minutes. In 
contrast, the livers perfused with UW functioned for variable 
lenghts of time over 30 min to 3 hr when the experiments were 
discontinued. No experiments were performed with organs simply 
stored in EC as previous work by our group has shown such organs 
not to be viable. 
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DISCUSSION 
The definitive assessment of hepatic viability after 
preservation is the capacity of the graft to survive after 
transplantation and to have all of its function restored (27). As an 
alternative model, an isolated perfused rat liver can be utilized to 
evaluate hepatic function during preservation, including 
measurement of the biochemical, metabolic, and morphologic 
integrity (28). 
NMR spectroscopy is a unique tool which allows repeated, non-
invasive measurement of metabolic changes in preserved organs that 
might be predictors of viability (29). The hepatic ATP level and the 
pHi can be readily assessed using 31 P-NMR spectroscopy and are 
thought to be important indicators of organ function (14, 15). 
Although no significant differences in longitudinal relaxation time 
(T 1) and saturation parameters for the observed phosphate 
metabolites were shown during various experimental phases and 
temperatures by other investigators (19), we cannot exclude the 
possibility that saturation may have occurred affecting the peak 
height of Pi, PM and ATP. For this reason, we included, after proper 
control experiments, an external reference (MDPA) for relative 
measures of phosphate metabolites. In addition, the same 31P-NMR 
recording schedule (2-sec delay, 70-msec pulse width) except during 
fructose challenge was always used, in order to minimize any errors 
in the relative intensity comparisons. 
Previous studies using 31 P-NMR (30-35) as well as other 
biochemical methods (36-38) have demonstrated that the ATP levels 
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decline rapidly after flushing the liver with non-oxygenated cold 
preservation solutions so that within a few hours no 31 P-NMR visible 
A TP signal can be observed. The time course of its disappearance 
varies depending on the type of solution and cooling modalities being 
used. The present results with simple cold storage of the liver 
confirm these findings. Moreover, no significant difference in the 
ATP decay during the cooling period was seen between UW and EG. 
Following reperfusion, the capacity of the liver to regenerate ATP 
has been touted as a reliable index of graft viability either in 
perfusion experiments (35, 39) or in the transplant recipient (11). 
I n recent clinical studies (12, 13), A TP levels within the donor liver 
have been shown to correlate positively with transplant outcome. 
In the present study, we monitored the ATP levels and the pHi 
in two experimental models of liver preservation: SGS and CHP. The 
first method has gained general acceptance in liver preservation, 
especially after the extension of the preservation time provided by 
the UW solution (4-8). The latter currently appears too complex to 
be clinically useful in liver transplantation (40) and the available 
human trials with this preservation technique have been performed 
only in kidney preservation (41). Recently, prolonged preservation 
time (72 hr) and subsequent successful liver transplantation have 
been obtained experimentally using CHP and a mq~ified UW solution 
(42, 43). To our knowledge no data is available on the hepatic ATP 
levels and pHi during continuos hypothermic perfusion. 
The important components of the UW solution which make it Ct. 
better preservation solution for the liver . as compared with 
solutions used previously is still uncertain (9, 44). Many 
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constituents appear to be important either individually or in 
combination. Several studies have demonstrated that not all of the 
ingredients of the UW solution are essential (45-47). However, both 
adenosine and phosphates, which enable ATP synthesis during 
hypothermia (48-50), are thought to be essential for the recovery of 
ATP levels upon reperfusion (10). While the important role of 
adenosine in the solution has been demonstrated using isolated liver 
cells (51), not all studies using other models have found it to be 
necessary (38, 47). The current findings of an improved ATP 
recovery after 24 hr SCS with UW and upon normothermic 
reperfusion are in agreement with most other reports (19, 35, 52, 
53) and suggest that the use of UW solution results in better liver 
viability as opposed to that achieved with the EC solution. On the 
other hand, when livers are continuously perfused for 24 hr at 8°C 
hepatic ATP levels are maintained at a low level with EC, and 
actually increase with time with UW perfusion. Indeed, on-line 
measurement of oxygen reveals some 02 consumption during CHP 
(results not shown). It should be noted that atter reperfusion both EC 
and UW-preserved livers recover similar levels of hepatic ATP in ~ 
hypothermically perfused for rat liver for 24 hr. Thus, the present 
data do not support the assumption that ATP precursors help the 
liver to recover during reperfusion (51). eowever~ it is possible that 
longer periods of CHP may allow a difference to be detected (42). 
The prevention of intracellular acidosis during cold storage is 
also an important function of the UW solution (9, 54). Cold ischemia 
activates anaerobic metabolism and a decline in the hepatic 
intracellular pH due to an increase in lactate and other factors (Le. 
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ATP hydrolysis) (55). Thus, a high buffer capacity, provided mainly 
by inorganic phosphates, is one of the crucial requirements for an 
efficacious preservation solution (9). 
The measurement of pHi using 31 P-NMR spectroscopy is based 
on the 31 P chemical shifts of the Pi and PM which are sensitive to 
changes in pH near their pKa (14, 15). The positions of these 
resonances can be used as a sensitive indicator of the intracellular 
pH. We used an external reference standard (MDPA) and two 
calibration plots for the observed 31 P chemical shifts of Pi and F-1-
P at different pHs using liver homogenate at different temperatures 
(15, 29, 56). A contribution to the Pi signal by the extracellular Pi 
cannot be avoided when using perfusate,s containing phosphates. 
However, different T 1 and relative saturation of the resonances 
(extra- vs intra-cellular) can be estimated (56), and utilized for 
correction of the measured 31 P signal intensities and chemical 
shifts. When Krebs-lactate is used, the liver/perfusate volume ratio 
in the control experiments (i.e. circulation only of perfusate and 
MDPA), allows us to estimate that the contribution of extracellular 
Pi to the observed 31 P-NMR Pi intensity (about 10%) is in agreement 
with previously reported findings (17, 56). This is further supported 
by observations during the fructose load that after 8 min the Pi peak 
is split into two peaks. As previously describ~d (17, 18), the 
intracellular Pi and pH decline promptly after giving fructose as 
seen by 31 P NMR. The upfield 31 P-NMR resonance is assumed to be 
the extracellular Pi component (Figure 1 b, Pi extra), and the pH is 
7.4, as expected. When UW or EC solutions are used, a larger 
contribution to the Pi peak intensity in the 31 P-NMR spectra is 
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observed as a result of the high phosphate content of these solutions 
(Figure 3), making the determination of pHi from Pi less accurate. In 
the case of Fuller and Busza (29), we determined the pHi by using 
the chemical shift of PM, whose pK is not ideal for the pH range 
studied. Therefore, pHi measurements under such experimental 
conditions can be considered to only be an approximation of the real 
value. 
The data herein presented relative to pHi during SCS confirm 
previous 31 P-NMR findings (19, 26, 53) and demonstrate the 
superiority of the UW solution in maintaining pHi near neutrality. 
The pHi was similar with either EC or UW with CHP, demonstrating a 
greater degree of maintenance of cellular metabolism with CHP over 
SCS at least for 24 hr. 
In the present work, a fructose challenge was used as an 
additional liver function test before and after preservation, because 
the biochemical events following its administration can be rapidly 
monitored by 31P-NMR spectroscopy (16-18). The response of the 
liver to the fructose load can be assessed by 31 P-NMR in terms of: (i) 
ability to take up the fructose load and its subsequent 
phosphorylation yielding an increase in the PM area; (ii) capacity to 
metabolize fructose with the return of the PM intensity to the pre-
challenge level; (iii) the changes of the Pi and th~ pHi: and (iv) the 
decline and the recovery in ATP levels. A baseline response to 
fructose under normothermic conditions was evaluated before 
preservation. The second challenge after 24 hr of SCS or HCP wa~ 
normalized to the baseline response. A recent study on the ability of 
fructose to protect the liver during hypoxia has been reported (57). 
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Under our conditions, the time elapsed between administration of 
the challenge and the start of preservation probably ensures the 
complete metabolism of the fructose. Thus, a direct protective role 
for this substance is most unlikely. In addition, pHi returned to a 
value close to the original baseline value 20 min after the fructose 
challenge. This finding essentially rules out a significant effect of 
the fructose load after the 24 hr of preservation. Other standard 
biochemical liver function parameters such as basal LDH release 
during different phases of the experimental design, 02 consumption 
and glucose production were stable within a single liver preparation 
during both fructose challenges. It is our experience with liver 
perfusion experiments with a perfusate ,solution like KL that a 
single fructose challenge produces alterations in the ATP spectra 
which can be restored to a maximal pre-fructose level (90%) even 
after several hours have elapsed (unpublished data). From the 
foregoing argument, even if a fructose effect were present before 
preservation, it would not be sufficient to explain the differences 
observed among the various groups studied, since all received 
fructose at identical times and at identical doses. In our study, the 
UW preserved livers demonstrated a better response to a fructose 
challenge than did EC preserved livers under both preservation 
techniques. These metabolic observations confirm, an earlier report 
using glucose formation as observed by 13C-NMR spectroscopy (52), 
and provide non-invasively acquired additional useful metabolic 
information relative to the viability of the liver after cold 
-" 
preservation. 
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Livers preserved for 24 hr with either EC or UW were 
transplanted orthotopically into other Sprague-Dawley rats and 
their short-term performance was monitored. Organs preserved by 
SCS technique with UW solution functioned for two or more days 
when the animals were sacrified. In contrast, those preserved by 
CHP technique functioned only for short periods of time. Those 
perfused with EC all experienced an increase in the portal venous 
perfusion pressure during the preservation period and functioned 
only for minutes after revascularization. Those perfused with UW 
functioned for 30 min to three hr when the experiments were 
discontinued because of portal venous thrombosis. These 
observations document clearly that he~atocyte preservation is 
obtained with the methods utilized in these experiments, but that 
portal vein (endothelial cells) injury occurs and limits the long-
term performance of the transplanted liver. 
Only livers that were simply stored with UW achieved 
prolonged survival after transplantation, while CHP livers were 
affected by vascular damage as demonstrated by fatal thrombosis 
after transplant, even when UW solution was used. These data 
suggest that preservation of the hepatic ATP content is not the only 
determinant of good liver function following transplantation. 
Finally, a different system of hypothermic perfusio!l which does not 
K~ 
injure endothelial cells might further improve liver preservation 
efficacy. 
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3Abbreviations used: AMP, adenosine monophosphate; ADP, adenosine 
diphosphate; ATP, adenosine triphosphate; CHP, continuous 
hypothermic perfusion; EC, Euro-Collins solution; F-1-P, fructose-1-
phosphate; KL, Krebs-lactate; MDPA, methylenediphosphonic acid; 
n.s., not significant; PCr, phosphocreatine; PO, phosphodiester; pHi, 
intracellular pH; Pi, inorganic phosphate; PM, phosphomonoester; 
31 P-NMR, phosphorus-31 nuclear magnetic resonance; ppm, parts per 
million; T1, longitudinal relaxation time; SCS, simple cold storage; 
SO, standard deviation of the mean; UW, University of Wisconsin 
solution. 
.;. 
TA
BL
E 
1 
Li
ve
r 
Tr
an
sp
l a
n
ta
t i 
on
 A
f t
e
r 
24
 H
ou
rs
 o
f 
Co
 I d
 S
to
ra
ge
 o
r 
O
rg
an
 P
er
f u
s 
i o
n 
P
re
se
rv
at
 I o
n 
S
ol
ut
io
n 
E
ur
o-
C
ol
l in
s 
UW
 
~ ..
 
,
',
t 
M
et
ho
d 
CH
P 
SC
S 
CH
P 
N
 2 2 2 4 
R
at
 
N
um
be
r 
1 2 1
 
*
*
 
1 2
t 
3
t 
4
t 
%
 L
iv
er
 
W
ei
gh
t 
Ch
an
ge
 
+
28
.9
 
+
51
.8
 
*
*
 
+
 11
.6
 -
+
26
.7
 
+
12
.5
 
+
40
.7
 
P
or
ta
l 
V
ei
n 
P
re
ss
ur
e 
C
ha
ng
e*
 
+
3 
em
 
+
7 
em
 
>
 3
 d
ay
s 
0 0 
-
0.
5 
em
 
+
3.
0 
e
m
 
S
ur
vi
va
l 
D
ur
at
io
n 
<
 1
5 
m
in
 
<
 1
5 
m
in
 
2 
da
ys
 
3 
hr
 
2 
hr
 
1 
hr
 
0.
5 
hr
 
*
 
Ch
an
ge
 i
n 
po
rt
al
 v
e
in
 (i
nf
lo
w)
 p
re
ss
ur
e 
du
rin
g 
th
e 
24
 h
ou
rs
 o
f 
pe
rf
us
io
n 
pr
es
er
va
tio
n.
 
*
*
 
N
ot
 m
e
a
su
re
d,
 b
ut
 u
s
u
a
lly
 d
ec
re
as
es
 6
-1
0%
 o
f 
in
iti
a
l 
w
e
ig
ht
. 
t 
P
or
ta
l v
e
in
 t
hr
om
bo
si
s 
o
c
c
u
rr
e
d 
te
rm
in
at
in
g 
th
e 
o
bs
er
va
tio
ns
. 
w
 
\0
 
_.--_ •... __ .. __ .-.... --
40 
FIGURE LEGENDS 
Figure 1 
31 P-NMR spectra of isolated rat liver perfused with Krebs-
lactate at 37°C, before and after a fructose load. 
Spectrum at before fructose. The resonances were assigned as 
follows: 1) methylenediphosphonic acid (MOPA), which is the 
external reference standard used for the chemical shift 
measurements [-19.8 ppm downfield from that of hypothetical 
phosphocreatine (Per)]; 2) phosphomonoesters (PM); 3) cytosolic 
inorganic phosphate (Pi); 4) phosphodiesters (PO); 5) ,,(-adenosine 
triphosphate (,,(-ATP) + ~-adenosine diphosphate E~-AlmF; 6) a-
adenosine triphosphate (a-ATP) + a-adenosine diphosphate (a-ADP); 
7) ~-adenosine triphosphate E~-AqmFK 
Spectru m!U: 8 min after fructose. After fructose administration 
(1.5 mmole/10 g wet liver weight in Krebs-lactate, 5-min infusion), 
an increase in PM peak area, mainly due to phosphorylation of 
fructose to fructose-1-phosphate (F-1-P), and a decrease in Pi and 
ATP areas are shown. Also note the splitting of the Pi peak and shift 
to the right of one component (Pi intra), whose frequency 
corresponds to pH 7.1. The other Pi component (Pi extra) corresponds 
to pH 7.4. The 31 P-NMR spectra were acquired in 4-min blocks with 
600 scans using a 0.3-sec interpulse delay and a 35-J,1sec pulse,: 
width. 
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Spectrum !.b.:.al: computerized difference between the above 31p_ 
NMR spectra. The hashed area above the baseline (F-1-P) equal the 
ones underneath (Pi, ATP) in absolute numbers (in parenthesis). 
Figure 2 
Phosphate metabolites changes after a fructose challenge 
as seen by 31P-NMR. 
The time-course of fructose-1-phosphate (F-1-P), inorganic 
phosphate (Pi) and ATP relative changes after a fructose load (0.15 
mmole/g wet liver weight in Krebs-lactate, 5:-min infusion, given at 
o time). Values as relative changes from basal value (100%) at 0 
time of phosphate metabolites areas (mean ± SO). 
Figure 3 
31 P-NMR spectra during 24 hours UW continuous 
hypothermic perfusion preservation (CHP). 
Sequence from 30 min to 24 hr of 31 P-NMR spectra of rat liver 
during CHP with UW solution, showing a very intense resonance from 
inorganic phosphate (Pj, peak 4), due to the high phosphate content of 
UW solution and the progressive increase (from f~ft to right, bottom 
. . 
to top) of a-ATP (peak 6) and ~-Aqm (peak 7) areas over time. The 
resonances were assigned as follows:1) methylenediphosphonic acid 
(MOPA), which is the external reference standard (-19.8 ppm,. 
downfield from that of hypothetical PCr); 2) phosphomonoesters 
(PM): including AMP and IMP; 3) phosphomonoesters (PM): including 
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sugar phosphates; 4) cytosolic inorganic phosphate (Pi); 5) "(-
adenosine triphosphate (,,{-ATP) + ~-adenosine diphosphate E~-AamF; 
6) a-adenosine triphosphate (a-ATP) + a-adenosine diphosphate (a-
ADP); 7) ~-adenosine triphosphate E~-AqmFK 31 P-NMR spectra were 
acquired in 30-min block with 900 scans using a 2-sec interpulse 
delay and a 70-J,l.sec pulse width. Each spectrum displays the same 
region between -30 ppm and +25 ppm. Following the first spectrum 
(30 min) all the others have been displaced laterally and only peaks 
6 and 7 were shown for clarity. 
Figure 4 
ATP content by 31 P-NMR spectroscopy during 24 hours 
perfusion preservation with UW and EC solutions. 
Relative changes of ~-Aqm area of 31 P-NMR spectra of rat livers at 
the end of each experimental phase of continuous hypothermic 
perfusion (CHP): i) 40 min after the first fructose load in Krebs-
lactate at 37°C before preservation (F1); ii) 30 min after switching 
to the cold preservation solution (cool); iii) after 24 hr of CHP at 6-
10°C (24 h); iv) 20 min after reperfusion with Krebs-lactate at 37°C 
(reper); v) 40 min after the second fructose load (F2). Relative 
concentrations were referred to an external standard (MOPA) to 
allow intra and intergroup statistical analysis. UW: University of 
Wisconsin, EC: EuroCollins. Values as mean ± SO from baseline value 
(100%) at 0 time. Student t test for unpaired data (* p<0.05, * * 
p<0.01 ). 
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